NEW_DDW_FujiFilm_Wako_Logo_400px copy
 
Albert Zhang_speaker_image_200px copy
Watch this engaging and informative webinar on Fujifilm Wako’s groundbreaking advancements in rabbit monoclonal antibody discovery. Traditional hybridoma technology has long struggled with inefficiencies, especially in producing rabbit monoclonal antibodies. Fujifilm Wako has surmounted these challenges by integrating DNA immunisation with its proprietary single B-cell cloning technique, paving the way for next-generation antibody production.

What you will learn:
  • Revolutionary DNA Immunisation Method: Discover how Fujifilm Wako’s DNA immunisation technique eliminates the need for purified antigen preparation. By directly injecting plasmids into rabbits, robust immune responses are induced, producing antibodies that recognise native protein forms, including complex targets like transmembrane proteins.
  • Proprietary Single B-Cell Cloning: Explore Fujifilm’s patented single B-cell cloning method (PAT: WO2024071374). This state-of-the-art technique allows for the efficient isolation and cloning of B-cells, resulting in monoclonal antibodies with exceptional affinity and specificity.
  • Advantages of Rabbit Antibodies: Learn about the superior performance of rabbit antibodies, which offer high affinity, diverse epitope recognition, and strong reactivity against rare or weak antigens. These qualities make them ideal for both therapeutic applications and diagnostic reagents.
  • Proven Expertise: With over 20 years of experience in antibody production, Fujifilm Wako has a track record of delivering high-quality antibodies using DNA immunisation in rats and mice. Now, this expertise is applied to rabbit monoclonal antibody production, providing reliable and effective solutions tailored to research needs.

    A Q&A session follows the webinar presentation.

Watch the webinar on-demand now!

Watch the Webinar